← all works
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- The Lancet
- Topic
- Diabetes Treatment and Management
- Field
- Medicine
- Canadian institutions
- University of TorontoSt. Michael's Hospital
- Funders
- —
- Keywords
- MedicineInternal medicineHeart failureHazard ratioMeta-analysisDiabetes mellitusStroke (engine)Myocardial infarctionAdverse effectRenal functionDiseaseCardiologyPlaceboType 2 diabetesProportional hazards modelClinical trialIntensive care medicineConfidence intervalEndocrinologyPathology
- Has abstract in OpenAlex
- no